NCT00517673View on ClinicalTrials.gov

To Evaluate Safety, Tolerability, Pharmacokinetics, And Food Effect Of Single Doses Of GSK945237 In Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

68

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions

Healthy SubjectsInfections, Bacterial

Interventions

DRUG

GSK945237

DRUG

Sugar Pill

Placebo

Trial Locations (1)

5000

GSK Investigational Site, Adelaide

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT00517673 - To Evaluate Safety, Tolerability, Pharmacokinetics, And Food Effect Of Single Doses Of GSK945237 In Healthy Subjects | Biotech Hunter | Biotech Hunter